English
Insider transactions
EDGARORIC Pharmaceuticals, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 16 transactions, 238,614 shares
- Sum of shares × price per share: 2,959,893.358
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 59
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-20 Filed 2026-10-21 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 14,000 | 4.36 | 61,040Derived: shares × price per share. Exact value 61040.00. | 83,828 | Direct (D) | Yes | — | Open filing 0001695028-26-000012 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-21 | Piscitelli Dominic Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 14,000 | 13.5279 | 189,390.6Derived: shares × price per share. Exact value 189390.6000. | 69,828 | Direct (D) | Yes | F1, F2
| Open filing 0001695028-26-000012 Read from the filing’s XML Dispute this row |
| 2026-10-20 Filed 2026-10-21 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 14,000 | 0 | — | 64,500 | Direct (D) | Yes | — | Open filing 0001695028-26-000012 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-02 | Heyman Richard A. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,500 | 1.60 | 5,600Derived: shares × price per share. Exact value 5600.00. | 41,800 | Direct (D) | Yes | — | Open filing 0001584759-26-000017 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-02 | Heyman Richard A. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,500 | 12.9141 | 45,199.35Derived: shares × price per share. Exact value 45199.3500. | 38,300 | Direct (D) | Yes | F1, F2
| Open filing 0001584759-26-000017 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-02 | Heyman Richard A. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,200 | 12.9141 | 41,325.12Derived: shares × price per share. Exact value 41325.1200. | 203,472 | Indirect (I) See footnote | Yes | F1, F2, F3
| Open filing 0001584759-26-000017 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-02 | Heyman Richard A. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,500 | 0 | — | 26,700 | Direct (D) | Yes | F4
| Open filing 0001584759-26-000017 Read from the filing’s XML Dispute this row |
| 2026-09-28 Filed 2026-09-29 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 13,400 | 4.36 | 58,424Derived: shares × price per share. Exact value 58424.00. | 83,228 | Direct (D) | Yes | — | Open filing 0001695028-26-000010 Read from the filing’s XML Dispute this row |
| 2026-09-28 Filed 2026-09-29 | Piscitelli Dominic Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 13,400 | 13.5267 | 181,257.78Derived: shares × price per share. Exact value 181257.7800. | 69,828 | Direct (D) | Yes | F1, F2
| Open filing 0001695028-26-000010 Read from the filing’s XML Dispute this row |
| 2026-09-28 Filed 2026-09-29 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 13,400 | 0 | — | 78,500 | Direct (D) | Yes | — | Open filing 0001695028-26-000010 Read from the filing’s XML Dispute this row |
| 2026-09-24 Filed 2026-09-25 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 600 | 4.36 | 2,616Derived: shares × price per share. Exact value 2616.00. | 70,428 | Direct (D) | Yes | — | Open filing 0001695028-26-000008 Read from the filing’s XML Dispute this row |
| 2026-09-24 Filed 2026-09-25 | Piscitelli Dominic Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 100 | 13.50 | 1,350Derived: shares × price per share. Exact value 1350.00. | 70,328 | Direct (D) | Yes | F1
| Open filing 0001695028-26-000008 Read from the filing’s XML Dispute this row |
| 2026-09-24 Filed 2026-09-25 | Piscitelli Dominic Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 500 | 13.505 | 6,752.5Derived: shares × price per share. Exact value 6752.500. | 69,828 | Direct (D) | Yes | F1
| Open filing 0001695028-26-000008 Read from the filing’s XML Dispute this row |
| 2026-09-24 Filed 2026-09-25 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 600 | 0 | — | 91,900 | Direct (D) | Yes | — | Open filing 0001695028-26-000008 Read from the filing’s XML Dispute this row |
| 2026-08-26 Filed 2026-08-28 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 52,000 | 4.36 | 226,720Derived: shares × price per share. Exact value 226720.00. | 121,828 | Direct (D) | Yes | F1
| Open filing 0001695028-26-000006 Read from the filing’s XML Dispute this row |
| 2026-08-26 Filed 2026-08-28 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 25,000 | 6 | 150,000Derived: shares × price per share. Exact value 150000. | 146,828 | Direct (D) | Yes | — | Open filing 0001695028-26-000006 Read from the filing’s XML Dispute this row |
| 2026-08-26 Filed 2026-08-28 | Piscitelli Dominic Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 77,000 | 13.6859 | 1,053,814.3Derived: shares × price per share. Exact value 1053814.3000. | 69,828 | Direct (D) | Yes | F2
| Open filing 0001695028-26-000006 Read from the filing’s XML Dispute this row |
| 2026-08-26 Filed 2026-08-28 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 52,000 | 0 | — | 92,500 | Direct (D) | Yes | — | Open filing 0001695028-26-000006 Read from the filing’s XML Dispute this row |
| 2026-08-26 Filed 2026-08-28 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 25,000 | 0 | — | 120,000 | Direct (D) | Yes | F3
| Open filing 0001695028-26-000006 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-28 | Heyman Richard A. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,500 | 1.60 | 5,600Derived: shares × price per share. Exact value 5600.00. | 45,300 | Direct (D) | Yes | — | Open filing 0001584759-26-000015 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-28 | Heyman Richard A. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,000 | 12.02 | 84,140Derived: shares × price per share. Exact value 84140.00. | 38,300 | Direct (D) | Yes | F1
| Open filing 0001584759-26-000015 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-28 | Heyman Richard A. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,100 | 12.02 | 73,322Derived: shares × price per share. Exact value 73322.00. | 206,672 | Indirect (I) See footnote | Yes | F1, F2
| Open filing 0001584759-26-000015 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-28 | Heyman Richard A. Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,500 | 0 | — | 30,200 | Direct (D) | Yes | F3
| Open filing 0001584759-26-000015 Read from the filing’s XML Dispute this row |
| 2026-07-06 Filed 2026-07-08 | Heyman Richard A. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 300 | 12 | 3,600Derived: shares × price per share. Exact value 3600. | 212,772 | Indirect (I) See footnote | Yes | F1, F2
| Open filing 0001584759-26-000012 Read from the filing’s XML Dispute this row |
| 2026-02-24 Filed 2026-02-26 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 52,000 | 4.36 | 226,720Derived: shares × price per share. Exact value 226720.00. | 120,148 | Direct (D) | Yes | — | Open filing 0001695028-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-24 Filed 2026-02-26 | Piscitelli Dominic Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 52,000 | 13.5132 | 702,686.4Derived: shares × price per share. Exact value 702686.4000. | 68,148 | Direct (D) | Yes | F1, F2
| Open filing 0001695028-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-24 Filed 2026-02-26 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 52,000 | 0 | — | 144,500 | Direct (D) | Yes | — | Open filing 0001695028-26-000004 Read from the filing’s XML Dispute this row |
| 2026-01-16 Filed 2026-01-20 | Heyman Richard A. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,500 | 12.0046 | 42,016.1Derived: shares × price per share. Exact value 42016.1000. | 41,800 | Direct (D) | Yes | F1, F2
| Open filing 0001584759-26-000006 Read from the filing’s XML Dispute this row |
| 2026-01-16 Filed 2026-01-20 | Heyman Richard A. Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,200 | 12.0046 | 38,414.72Derived: shares × price per share. Exact value 38414.7200. | 213,072 | Indirect (I) See footnote | Yes | F1, F2, F3
| Open filing 0001584759-26-000006 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Chacko Jacob Director · Officer: PRESIDENT AND CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 675,000 | 0 | — | 675,000 | Direct (D) | No | F1
| Open filing 0001608936-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Chacko Jacob Director · Officer: PRESIDENT AND CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 112,500 | 0 | — | 112,500 | Direct (D) | No | F2, F3
| Open filing 0001608936-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Hoerter Steven L. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,000 | 0 | — | 40,000 | Direct (D) | No | F1
| Open filing 0001533451-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Kunkel Lori Anne Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,000 | 0 | — | 40,000 | Direct (D) | No | F1
| Open filing 0001536368-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Dier Mardi Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,000 | 0 | — | 40,000 | Direct (D) | No | F1
| Open filing 0001574591-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Piscitelli Dominic Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 206,500 | 0 | — | 206,500 | Direct (D) | No | F1
| Open filing 0001695028-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Piscitelli Dominic Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 34,500 | 0 | — | 34,500 | Direct (D) | No | F2, F3
| Open filing 0001695028-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Heyman Richard A. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,000 | 0 | — | 40,000 | Direct (D) | No | F1
| Open filing 0001584759-26-000003 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | You Angie Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 40,000 | 0 | — | 40,000 | Direct (D) | No | F1
| Open filing 0001647664-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Multani Pratik S Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 214,000 | 0 | — | 214,000 | Direct (D) | No | F1
| Open filing 0001586894-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Multani Pratik S Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 35,500 | 0 | — | 35,500 | Direct (D) | No | F2, F3
| Open filing 0001586894-26-000002 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-17 | Multani Pratik S Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,720 | 9.0605 | 97,128.56Derived: shares × price per share. Exact value 97128.5600. | 68,149 | Direct (D) | No | F3, F4
| Open filing 0001586894-25-000005 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-17 | Piscitelli Dominic Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,720 | 9.0604 | 97,127.488Derived: shares × price per share. Exact value 97127.4880. | 68,148 | Direct (D) | No | F3, F4
| Open filing 0001695028-25-000008 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-17 | Chacko Jacob Director · Officer: PRESIDENT AND CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 33,374 | 9.06 | 302,368.44Derived: shares × price per share. Exact value 302368.44. | 581,711 | Direct (D) | No | F2, F3
| Open filing 0001608936-25-000014 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2025-12-17 | Multani Pratik S Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 29,333 | 0 | — | 78,869 | Direct (D) | No | F1, F2
| Open filing 0001586894-25-000005 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2025-12-17 | Multani Pratik S Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 8,000 | 0 | — | 0 | Direct (D) | No | F1, F5
| Open filing 0001586894-25-000005 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2025-12-17 | Multani Pratik S Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 10,000 | 0 | — | 10,000 | Direct (D) | No | F1, F6
| Open filing 0001586894-25-000005 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2025-12-17 | Multani Pratik S Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 11,333 | 0 | — | 22,667 | Direct (D) | No | F1, F7
| Open filing 0001586894-25-000005 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2025-12-17 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 29,333 | 0 | — | 78,868 | Direct (D) | No | F1, F2
| Open filing 0001695028-25-000008 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2025-12-17 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 8,000 | 0 | — | 0 | Direct (D) | No | F1, F5
| Open filing 0001695028-25-000008 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2025-12-17 | Piscitelli Dominic Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 10,000 | 0 | — | 10,000 | Direct (D) | No | F1, F6
| Open filing 0001695028-25-000008 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.
Showing 1–50 of 215
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Nextech Invest Ltd. | 7,162,637 SH | 96,480,720 dollars | Unchanged Prior quarter: 7,162,637 | Open filing 0001595430-26-000015 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 6,979,451 SH | 94,013,206 dollars | Higher by 155,478 Prior quarter: 6,823,973 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager | 5,088,495 SH | 68,543 dollars | Lower by 1,529,059 Prior quarter: 6,617,554 | Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row |
| AIHC Capital Management Ltd | 4,630,986 SH | 62,379,381 dollars | Higher by 802,526 Prior quarter: 3,828,460 | Open filing 0001172661-26-005109 Filed 2026-11-16 Dispute this row |
| SR ONE CAPITAL MANAGEMENT, LP | 4,615,384 SH | 62,169,223 dollars | Unchanged Prior quarter: 4,615,384 | Open filing 0001012975-26-001062 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 4,126,317 SH | 55,581,490 dollars | Lower by 767,683 Prior quarter: 4,894,000 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| NEA Management Company, LLC | 4,118,621 SH | 55,477,825 dollars | Unchanged Prior quarter: 4,118,621 | Open filing 0001072613-26-000901 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,072,661 SH | 54,858,744 dollars | Higher by 121,492 Prior quarter: 3,951,169 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| VIKING GLOBAL INVESTORS LP | 3,562,915 SH | 47,992,465 dollars | Lower by 1,563,847 Prior quarter: 5,126,762 | Open filing 0001103804-26-000010 Filed 2026-11-16 Dispute this row |
| Column Group LLC | 3,540,777 SH | 47,694,266 dollars | Unchanged Prior quarter: 3,540,777 | Open filing 0001193125-26-463528 Filed 2026-11-16 Dispute this row |
| Siren, L.L.C. Partly reported under another manager | 3,358,192 SH | 45,234,846 dollars | Higher by 360,000 Prior quarter: 2,998,192 | Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row |
| ALKEON CAPITAL MANAGEMENT LLC Partly reported under another manager | 3,239,096 SH | 43,630,623 dollars | Lower by 500,000 Prior quarter: 3,739,096 | Open filing 0000919574-26-007849 Filed 2026-11-16 Dispute this row |
| EcoR1 Capital, LLC | 3,028,116 SH | 40,788,723 dollars | Lower by 3,700,000 Prior quarter: 6,728,116 | Open filing 0000935836-26-000577 Filed 2026-11-16 Dispute this row |
| Venrock Adviser, LLC | 2,944,056 SH | 39,656,434 dollars | Lower by 1,375,709 Prior quarter: 4,319,765 | Open filing 0001615982-26-000019 Filed 2026-11-16 Dispute this row |
| FMR LLC Partly reported under another manager | 2,631,943 SH | 35,452,272 dollars | Lower by 3,532 Prior quarter: 2,635,475 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| D. E. Shaw Co., Inc. Partly reported under another manager | 2,453,873 SH | 33,053,670 dollars | Higher by 873,657 Prior quarter: 1,580,216 | Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row |
| Defilade Capital Management, L.P. | 2,272,497 SH | 30,610,535 dollars | Higher by 1,224,807 Prior quarter: 1,047,690 | Open filing 0002088557-26-000010 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 2,193,715 SH | 29,555,467 dollars | Higher by 103,626 Prior quarter: 2,090,089 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 2,111,325 SH | 28,439,548 dollars | Lower by 483,974 Prior quarter: 2,595,299 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 2,036,262 SH | 27,428,449 dollars | Higher by 242,242 Prior quarter: 1,794,020 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| DIMENSIONAL FUND ADVISORS LP Partly reported under another manager | 1,900,144 SH | 25,594,064 dollars | Higher by 98,745 Prior quarter: 1,801,399 | Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 1,886,170 SH | 17,616,828 dollars | Higher by 88,793 Prior quarter: 1,797,377 | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| MPM BIOIMPACT LLC | 1,821,951 SH | 24,541,680 dollars | Lower by 60,211 Prior quarter: 1,882,162 | Open filing 0001193125-26-463462 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 1,801,571 SH | 24,267,162 dollars | Lower by 650,225 Prior quarter: 2,451,796 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Integral Health Asset Management, LLC | 1,700,000 SH | 20,205,000 dollars | Lower by 200,000 Prior quarter: 1,900,000 | Open filing 0001172661-26-005192 Filed 2026-11-16 Dispute this row |
| Qube Research Technologies Ltd | 1,642,227 SH | 22,120,798 dollars | Higher by 847,685 Prior quarter: 794,542 | Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row |
| ALGERT GLOBAL LLC Partly reported under another manager | 1,621,908 SH | 21,847,101 dollars | Higher by 406,615 Prior quarter: 1,215,293 | Open filing 0001275218-26-000018 Filed 2026-11-17 Dispute this row |
| First Turn Management, LLC | 1,574,334 SH | 21,206,279 dollars | Lower by 442,950 Prior quarter: 2,017,284 | Open filing 0001993440-26-000005 Filed 2026-11-16 Dispute this row |
| ORBIMED ADVISORS LLC | 1,555,900 SH | 20,957,973 dollars | Lower by 459,100 Prior quarter: 2,015,000 | Open filing 0001172661-26-005349 Filed 2026-11-16 Dispute this row |
| Paradigm Biocapital Advisors LP | 1,505,769 SH | 20,282,708 dollars | Not in the prior quarter’s filings read | Open filing 0001855655-26-000020 Filed 2026-11-16 Dispute this row |
| Woodline Partners LP | 1,433,961 SH | 19,315,455 dollars | Higher by 186,446 Prior quarter: 1,247,515 | Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,286,565 SH | 17,330,031 dollars | Higher by 234,662 Prior quarter: 1,051,903 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| Casdin Capital, LLC | 1,250,000 SH | 16,837,500 dollars | Not in the prior quarter’s filings read | Open filing 0000919574-26-008113 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 1,039,224 SH | 13,998,348 dollars | Lower by 38,831 Prior quarter: 1,078,055 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Squadron Capital Management LLC | 1,000,000 SH | 13,470,000 dollars | Not in the prior quarter’s filings read | Open filing 0002050709-26-000036 Filed 2026-11-16 Dispute this row |
| BRAIDWELL LP | 990,959 SH | 13,348,218 dollars | Lower by 223,581 Prior quarter: 1,214,540 | Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row |
| Euclidean Capital LLC | 989,410 SH | 13,327,353 dollars | Unchanged Prior quarter: 989,410 | Open filing 0001012975-26-001061 Filed 2026-11-16 Dispute this row |
| Vivo Capital, LLC | 924,392 SH | 12,451,560 dollars | Lower by 924,394 Prior quarter: 1,848,786 | Open filing 0001213900-26-119459 Filed 2026-11-13 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 803,245 SH | 10,819,710 dollars | Lower by 3,059 Prior quarter: 806,304 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| Candriam S.C.A. | 788,125 SH | 10,654,831 dollars | Lower by 391,643 Prior quarter: 1,179,768 | Open filing 0001537014-26-000009 Filed 2026-11-03 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 771,418 SH | 10,391,000 dollars | Higher by 93,595 Prior quarter: 677,823 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| Frazier Life Sciences Management, L.P. | 751,672 SH | 10,125,022 dollars | Not in the prior quarter’s filings read | Open filing 0001892134-26-000007 Filed 2026-11-16 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 713,325 SH | 9,608,488 dollars | Higher by 15,631 Prior quarter: 697,694 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| SILVERARC CAPITAL MANAGEMENT, LLC Option: Call | 702,400 SH | 9,461,328 dollars | Higher by 19,800 Prior quarter: 682,600 | Open filing 0001420506-26-002577 Filed 2026-11-12 Dispute this row |
| NEXTBio Capital Management LP | 684,476 SH | 9,219,892 dollars | Lower by 21,648 Prior quarter: 706,124 | Open filing 0001172661-26-004969 Filed 2026-11-13 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 648,205 SH | 8,731,321 dollars | Higher by 19,523 Prior quarter: 628,682 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 604,415 SH | 8,141,470 dollars | Higher by 38,377 Prior quarter: 566,038 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| AQR CAPITAL MANAGEMENT LLC Partly reported under another manager | 588,639 SH | 7,928,968 dollars | Higher by 229,888 Prior quarter: 358,751 | Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row |
| ArrowMark Colorado Holdings LLC | 582,875 SH | 7,851,326 dollars | Unchanged Prior quarter: 582,875 | Open filing 0001172661-26-005265 Filed 2026-11-16 Dispute this row |
| Connor, Clark Lunn Investment Management Ltd. | 556,369 SH | 7,494,290 dollars | Higher by 37,909 Prior quarter: 518,460 | Open filing 0001596800-26-000018 Filed 2026-11-10 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- EVENTIDE ASSET MANAGEMENT, LLC 954,768 SH
- Jones Hill Capital LP 747,313 SH
- Sixth Street Partners Management Company, L.P. 677,823 SH
- SUPERSTRING CAPITAL MANAGEMENT LP 406,077 SH
- Blue Owl Capital Holdings LP 400,000 SH
- Boxer Capital Management, LLC 350,000 SH
- SPHERA FUNDS MANAGEMENT LTD. 100,000 SH
- SG Americas Securities, LLC 52,089 SH
- Caption Management, LLC 48,130 SH
- Sound Capital Solutions LLC 32,216 SH
- Balyasny Asset Management L.P. 24,201 SH
- INTECH INVESTMENT MANAGEMENT LLC 20,143 SH
- Blueshift Asset Management, LLC 15,371 SH
- Jupiter Topco LLC 14,400 SH
- DRW Securities, LLC 14,312 SH
- E Fund Management Co., Ltd. 12,798 SH
- CANADA PENSION PLAN INVESTMENT BOARD 11,800 SH
- PRELUDE CAPITAL MANAGEMENT, LLC 11,300 SH
- Quantbot Technologies LP 4,280 SH
- Integrated Wealth Concepts LLC 3,497 SH
- Pacer Advisors, Inc. 1,516 SH
- SIMPLEX TRADING, LLC 400 SH
- Optiver Holding B.V. 248 SH
- State of Wyoming 89 SH
- Stone House Investment Management, LLC 18 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC Common Stock | 2.9 | 3,028,116 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-26-000590 Dispute this row |
| Oleg Nodelman Common Stock | 2.9 | 3,028,116 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-26-000590 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 2.8 | 2,885,435 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-26-000590 Dispute this row |
| T. Rowe Price Associates, Inc. COMMON STOCK | 4.9 | 5,088,495 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000080255-26-000706 Dispute this row |
| VIKING GLOBAL INVESTORS LP Common Stock, $0.0001 par value per share | 5.7 | 6,002,989 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| Viking Global Opportunities Parent GP LLC Common Stock, $0.0001 par value per share | 5.7 | 6,002,989 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| Viking Global Opportunities GP LLC Common Stock, $0.0001 par value per share | 3.5 | 3,766,111 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| Viking Global Opportunities Portfolio GP LLC Common Stock, $0.0001 par value per share | 3.5 | 3,766,111 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| Viking Global Opportunities Illiquid Investments Sub-Master LP Common Stock, $0.0001 par value per share | 3.5 | 3,766,111 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| Viking Global Opportunities Drawdown GP LLC Common Stock, $0.0001 par value per share | 2.1 | 2,236,878 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| Viking Global Opportunities Drawdown Portfolio GP LLC Common Stock, $0.0001 par value per share | 2.1 | 2,236,878 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| Viking Global Opportunities Drawdown (Aggregator) LP Common Stock, $0.0001 par value per share | 2.1 | 2,236,878 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| HALVORSEN OLE ANDREAS Common Stock, $0.0001 par value per share | 5.7 | 6,002,989 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| Shabet Rose Sharon Common Stock, $0.0001 par value per share | 5.7 | 6,002,989 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0000905148-26-004951 Dispute this row |
| VIKING GLOBAL INVESTORS LP Common Stock, $0.0001 par value per share | 7.8 | 8,264,607 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| Viking Global Opportunities Parent GP LLC Common Stock, $0.0001 par value per share | 7.8 | 8,264,607 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| Viking Global Opportunities GP LLC Common Stock, $0.0001 par value per share | 5 | 5,250,103 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| Viking Global Opportunities Portfolio GP LLC Common Stock, $0.0001 par value per share | 5 | 5,250,103 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| Viking Global Opportunities Illiquid Investments Sub-Master LP Common Stock, $0.0001 par value per share | 5 | 5,250,103 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| Viking Global Opportunities Drawdown GP LLC Common Stock, $0.0001 par value per share | 2.8 | 3,014,504 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| Viking Global Opportunities Drawdown Portfolio GP LLC Common Stock, $0.0001 par value per share | 2.8 | 3,014,504 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| Viking Global Opportunities Drawdown (Aggregator) LP Common Stock, $0.0001 par value per share | 2.8 | 3,014,504 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| HALVORSEN OLE ANDREAS Common Stock, $0.0001 par value per share | 7.8 | 8,264,607 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| Shabet Rose Sharon Common Stock, $0.0001 par value per share | 7.8 | 8,264,607 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000905148-26-002430 Dispute this row |
| T. Rowe Price Associates, Inc. COMMON STOCK | 5.4 | 5,387,783 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0000080255-26-000420 Dispute this row |
| Venrock Healthcare Capital Partners III, L.P. Common Stock, par value $0.0001 per share | 4.2 | 4,319,765.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001738048-26-000058 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, par value $0.0001 per share | 4.2 | 4,319,765.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001738048-26-000058 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, par value $0.0001 per share | 4.2 | 4,319,765.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001738048-26-000058 Dispute this row |
| VHCP Management III, LLC Common Stock, par value $0.0001 per share | 4.2 | 4,319,765.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001738048-26-000058 Dispute this row |
| VHCP Management EG, LLC Common Stock, par value $0.0001 per share | 4.2 | 4,319,765.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001738048-26-000058 Dispute this row |
| Nimish Shah Common Stock, par value $0.0001 per share | 4.2 | 4,319,765.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001738048-26-000058 Dispute this row |
| Bong Y. Koh Common Stock, par value $0.0001 per share | 4.2 | 4,319,765.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001738048-26-000058 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.0001 per share | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003469 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.0001 per share | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003469 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.0001 per share | 0 | 0.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003469 Dispute this row |
| Venrock Healthcare Capital Partners III, L.P. Common Stock, par value $0.0001 per share | 5.8 | 5,676,230.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000026 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, par value $0.0001 per share | 5.8 | 5,676,230.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000026 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, par value $0.0001 per share | 5.8 | 5,676,230.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000026 Dispute this row |
| VHCP Management III, LLC Common Stock, par value $0.0001 per share | 5.8 | 5,676,230.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000026 Dispute this row |
| VHCP Management EG, LLC Common Stock, par value $0.0001 per share | 5.8 | 5,676,230.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000026 Dispute this row |
| Nimish Shah Common Stock, par value $0.0001 per share | 5.8 | 5,676,230.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000026 Dispute this row |
| Bong Y. Koh Common Stock, par value $0.0001 per share | 5.8 | 5,676,230.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000026 Dispute this row |
| BlackRock, Inc. Common Stock | 5.6 | 5,473,145 | 12/31/2025 Filed 2026-01-21 | SCHEDULE 13G | Open filing 0002012383-26-000702 Dispute this row |
| The Column Group II, LP Common Stock, $0.0001 par value per share | 3.6 | 3,540,777 | 09/30/2025 Filed 2025-11-17 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-25-284976 Dispute this row |
| The Column Group II GP, LP Common Stock, $0.0001 par value per share | 3.6 | 3,540,777 | 09/30/2025 Filed 2025-11-17 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-25-284976 Dispute this row |
| David V Goeddel Common Stock, $0.0001 par value per share | 3.7 | 3,627,493 | 09/30/2025 Filed 2025-11-17 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-25-284976 Dispute this row |
| Peter Svennilson Common Stock, $0.0001 par value per share | 3.7 | 3,644,118 | 09/30/2025 Filed 2025-11-17 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-25-284976 Dispute this row |
| Alkeon Capital Management LLC Common Stock, par value $0.0001 per share | 4.6 | 4,504,096.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000902664-25-004920 Dispute this row |
| Panayotis D. Sparaggis Common Stock, par value $0.0001 per share | 4.6 | 4,504,096.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000902664-25-004920 Dispute this row |
| SR One Capital Management, LLC Common Stock, $0.0001 par value per share | 4.75 | 4,615,384 | 08/12/2025 Filed 2025-08-14 | SCHEDULE 13D/AAmendment 1 | Open filing 0000950170-25-108850 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,722,084 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 138,466 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.